Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2003
10/08/2003EP1350113A2 Inhibition of cmv infection and dissemination
10/08/2003EP1349964A2 Method for the prediction of the risk potential for cancerous diseases and inflammatory intestinal diseases and corresponding tests
10/08/2003EP1349944A2 Latency associated peptide for providing latency to pharmaceutically active proteins
10/08/2003EP1349942A2 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
10/08/2003EP1349940A2 55562 and 21617, novel human proteins and methods of use thereof
10/08/2003EP1349936A2 Regulation of human b7-h2 protein
10/08/2003EP1349932A2 Novel human secreted proteins and polynucleotides encoding the same
10/08/2003EP1349930A2 Human proteins, polynucleotides encoding them and methods of using the same
10/08/2003EP1349929A2 Apoptosis-inducing dna sequences
10/08/2003EP1349928A2 A novel human g-protein coupled reciptor hgprbmy11 expressed highly in heart and variants thereof
10/08/2003EP1349927A2 Method for inhibiting the expression of a target gene and medicament for treating a tumor disease
10/08/2003EP1349926A2 Complementing cell lines
10/08/2003EP1349925A2 Functional balanced-lethal host-vector systems
10/08/2003EP1349924A2 Methods and compositions for the diagnosis of cancer susceptibilites and defective dna repair mechanisms and treatment thereof
10/08/2003EP1349919A1 Extramedullary adipose tissue cells and use thereof for regenerating hematopoietic and muscular tissues
10/08/2003EP1349918A1 Method of collecting placental stem cells
10/08/2003EP1349870A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1349577A2 Intracellular delivery of charged therapeutic moieties to nerve cells by means of targeting proteins
10/08/2003EP1349568A1 Immunomodulatory constructs and their uses
10/08/2003EP1349565A2 Regulation of cell proliferation and differentiation using topically applied nucleic acid molecules
10/08/2003EP1349485A2 Compositions and methods for the therapy and diagnosis of ovarian cancer
10/08/2003EP1073455B1 Compositions and methods for extending the action of clostridial neurotoxin
10/08/2003EP0920523B1 Hsv strain lacking functional icp27 and icp34.5 genes
10/08/2003EP0882130B1 Human cancer antigen of tyrosinase-related protein 1 and gene encoding same
10/08/2003EP0750628B1 Fibroblast growth factor-10
10/08/2003EP0743948B2 Separation of nucleic acids by chromatography
10/08/2003CN1447920A Compsns. and methods for modulating tumor specific expression
10/08/2003CN1447858A Complex
10/08/2003CN1447857A Agonist anti-TRK-C monoclonal antibodies
10/08/2003CN1447819A Human CYR 61
10/08/2003CN1447700A Virus vector for transferring gene into renal cells
10/08/2003CN1447683A Polymeric micelle compsns.
10/08/2003CN1123574C Ligands for FLT3 receptors
10/07/2003US6630613 Mouse whose genome comprises a disruption of large tumor suppressor (lats) protein; use in treatment of cancer and hyperproliferative disorders; use antagonists in growing larger animals and plants
10/07/2003US6630455 Methods for inducing mucosal immune responses
10/07/2003US6630448 Isolated endostatin, especially approximately 20 kDa and corresponds to a C-terminal fragment of collagen type XVIII
10/07/2003US6630351 Transfecting a cell by attaching a reversible labile membrane activity inhibitor to a melittin peptide; adding peptide to solution containing the nucleic acid; endocytosis
10/07/2003US6630349 Trophoblast cell preparations
10/07/2003US6630348 Single-chain insulin analog and a polynucleotide sequence encoding the analog
10/07/2003US6630346 Gene therapy for obesity
10/07/2003US6630344 Adenoviral vectors; use for gene therapy, vaccines and for the transformation of cells
10/07/2003US6630343 Hepatitis C virus culture system
10/07/2003US6630326 Cancer diagnosis and therapy based on mutations in TGF-β receptors
10/07/2003US6630322 Adenovirus comprising DNA with a origin of replication of epstein-barr virus, promoter, nucleotide sequence encoding a protein and internal ribosome entry site sequence of an encephalomyocarditis virus; site-specific recombination
10/07/2003US6630318 Prognostic evaluation of cancer
10/07/2003US6630304 Human osteoporosis gene
10/07/2003US6630143 Monoclonal antibodes, treating hematopoietic disorders, in particular, aplastic anemia and myelodysplastic syndromes
10/07/2003US6630138 Protein C derivatives
10/07/2003CA2280290C Netrin receptors
10/07/2003CA2237807C Recombinant poxvirus-feline infectious peritonitis virus, compositions thereof and methods for making and using them
10/02/2003WO2003081258A2 Diagnostics and therapeutics for diseases associated with growth hormone secretagogue receptor (ghs)
10/02/2003WO2003081250A1 Novel compositions and methods in cancer associated with altered expression of prlr
10/02/2003WO2003080853A1 Novel compositions and methods in cancer associated with altered expression of tbx21
10/02/2003WO2003080847A1 Cationic amphiphiles for intracellular delivery of therapeutic molecules its composition, process and use thereof
10/02/2003WO2003080836A1 Nerve regeneration genes
10/02/2003WO2003080835A1 Erbb3 based methods and compositions for treating neoplasms
10/02/2003WO2003080831A1 Nuclear receptor errϝ3
10/02/2003WO2003080825A2 Further bmp-2 inducible kinases and the uses thereof
10/02/2003WO2003080806A2 Method for production of neutrophils and uses therefor
10/02/2003WO2003080804A2 Regulation of ins(3456)p4 signalling by a reversible kinase/phosphatase and methods and compositions related thereto
10/02/2003WO2003080794A2 Inhibition of rna function by delivery of inhibitors to animal cells
10/02/2003WO2003080648A2 Raav vector compositions and methods for the treatment of choroidal neovascularization
10/02/2003WO2003080640A1 Lymphatic and blood endothelial cell genes
10/02/2003WO2003080639A1 Novel compositions and methods in cancer associated with altered expression of kcnj9
10/02/2003WO2003080638A2 Antisense iap nucleobase oligomers and uses thereof
10/02/2003WO2003080122A1 Method and agent for producing therapeutically active blood compositions
10/02/2003WO2003080116A1 Modulating angiogenesis
10/02/2003WO2003080112A2 Imidazoquinolineamines as adjuvants in hiv dna vaccination
10/02/2003WO2003080105A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
10/02/2003WO2003080083A1 Use of adenoviruses mutated in the va genes for cancer treatment
10/02/2003WO2003079982A2 Gene amplification in cancer
10/02/2003WO2003079977A2 Novel compositions and methods in cancer associated with altered expression of mcm3ap
10/02/2003WO2003079967A2 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
10/02/2003WO2003079757A2 Hiv therapeutic
10/02/2003WO2003064441A3 Oligonucleotides comprising alternating segments and uses thereof
10/02/2003WO2003062414A3 Methods of obtaining isoform specific expression in mammalian cells
10/02/2003WO2003062394A9 Methods and compositions for rna interference
10/02/2003WO2003061629A3 Dna dosage forms
10/02/2003WO2003060121A9 Compositions and methods relating to gastric specific genes and proteins
10/02/2003WO2003054154A3 Antisense modulation of mucin 1, transmembrane expression
10/02/2003WO2003046180A3 Human cdnas and proteins and uses thereof
10/02/2003WO2003035694A3 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof
10/02/2003WO2003013593A3 Composite superimmunogen for bi-functional vaccine use for the treatment of illnesses associated with a stromal tissue disorder
10/02/2003WO2003004655A3 Use of the cd24 marker gene for the selection of keratinocyte stem cells transformed by exogenous sequences
10/02/2003WO2002099056A3 C22c7orfs as modifiers of the p53 pathway and methods of use
10/02/2003WO2002090382A3 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
10/02/2003WO2002081712A3 Artificial chromosomes comprising ehv sequences
10/02/2003WO2002074323A3 Using neural thread proteins to treat tumors and other hyperproliferative disorders
10/02/2003WO2002061037A3 Administration of nucleic acid sequence to female animal
10/02/2003WO2002057419A3 Protein-protein interactions
10/02/2003WO2002026246A3 Pharmaceutical compositions comprising polynucleotides encoding a raf protein
10/02/2003WO2002022809A3 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
10/02/2003WO2002022573A3 Methods and compositions relating to hydrogen peroxide and superoxide production by antibodies
10/02/2003WO2002006315A3 Novel nucleic acid and amino acid sequences
10/02/2003WO2001090155A3 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
10/02/2003US20030188327 Compositions and methods for the treatment and diagnosis of cardiovascular disease
10/02/2003US20030187245 Comprises expression vectors coding proteins for regulation and expression of transgenes and treatment of allergies, inflammation, arthritis and nervous system disorders; gene therapy; antiproliferative agents
10/02/2003US20030187240 Nuclease resistant
10/02/2003US20030187219 Regulation of human alpha 1A adrenergic receptor-line G protein-coupled receptor
10/02/2003US20030186936 Gene therapy; lyases; hyaluronidase; anticancer agents (retinoblastomas); kits
1 ... 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 ... 870